<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04051879</url>
  </required_header>
  <id_info>
    <org_study_id>182110</org_study_id>
    <nct_id>NCT04051879</nct_id>
  </id_info>
  <brief_title>Influence of Reward and Punishment on Goal-directed and Habit Learning in Adolescent Anorexia Nervosa</brief_title>
  <official_title>Influence of Reward and Punishment on Goal-directed and Habit Learning in Adolescent Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study of adolescents with anorexia nervosa (AN) will examine the association of&#xD;
      behavioral differences in constructs of decision making, brain structure and connectivity,&#xD;
      and eating disorder (ED) symptoms. This study tests the novel hypothesis that goal-directed&#xD;
      and habit learning for reward and punishment is altered in AN and is uniquely associated with&#xD;
      divergent symptoms and differences in corticostriatal connectivity and microstructural&#xD;
      integrity. We will recruit 78 females currently ill with AN and 26 controls ages 13-17 to&#xD;
      investigate how goal-directed and habit learning for reward and punishment correspond to 1)&#xD;
      clinical symptoms collected via interviews, self-report assessments, and ecological momentary&#xD;
      assessment (EMA), and 2) brain structure and connectivity in the resting state. Data&#xD;
      collection will rely on a technology called functional magnetic resonance imaging (fMRI).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Learning Task</measure>
    <time_frame>Computer Task (Baseline)</time_frame>
    <description>A learning computer task will be used to dissociate model-based and model-free learning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brain Function</measure>
    <time_frame>fMRI Scan (Baseline)</time_frame>
    <description>Functional Magnetic Resonance Imaging will be used to correlate brain function with a weighting factor (Ï‰), representing the relative balance between learning biases.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>AN-R</arm_group_label>
    <description>Participants that meet Diagnostic And Statistical Manual Of Mental Disorders (DSM-V) criteria for Anorexia Nervosa restricting subtype.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AN-BP</arm_group_label>
    <description>Participants that meet DSM-V criteria for Anorexia Nervosa binging/purging subtype.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Participants that do not meet DSM-V criteria for any disorder.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We will recruit from a clinical sample for the AN groups. We will recruit from a community&#xD;
        sample for the healthy control group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        AN Group:&#xD;
&#xD;
          -  Between the ages of 13 and 17 years old&#xD;
&#xD;
          -  Meet DSM-V criteria for AN-R or AN-BP&#xD;
&#xD;
          -  Medically stable per American Academy of Pediatrics and the Society of Adolescent&#xD;
             Medicine requirements, at least 75% adjusted ideal body weight, but still symptomatic&#xD;
             as assessed by the Eating Disorders Examination and clinical report&#xD;
&#xD;
          -  Be at least 75% of adjusted ideal body weight&#xD;
&#xD;
        Healthy Control Group:&#xD;
&#xD;
          -  Between the ages of 13 and 17 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        All Groups:&#xD;
&#xD;
          -  Psychotic illness/other mental illness requiring hospitalization&#xD;
&#xD;
          -  Current dependence on drugs or alcohol defined by DSM IV criteria. Additionally,&#xD;
             positive test results for drug use on the day of the scan, apart of marijuana, will&#xD;
             result in cancelling or rescheduling the scan because acute use will impact MRI&#xD;
             measures.&#xD;
&#xD;
          -  Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or&#xD;
             weight&#xD;
&#xD;
          -  Neurological disorder, neurodevelopmental disorder, or history of head injury with &gt;30&#xD;
             min loss of consciousness&#xD;
&#xD;
          -  Any contraindication to undergoing an MRI&#xD;
&#xD;
          -  Primary obsessive compulsive disorder or primary major depressive disorder&#xD;
&#xD;
        Additional Exclusion Criteria for AN Group:&#xD;
&#xD;
          -  If taking other psychotropic medication, any change in dosage in the 2 weeks before&#xD;
             scanning&#xD;
&#xD;
        Additional Exclusion Criteria for Healthy Control Group:&#xD;
&#xD;
          -  Meet or met criteria for the diagnosis of any psychiatric disorder in their lifetime&#xD;
&#xD;
          -  Any history of binge eating or purging behaviors, including self-induced vomiting,&#xD;
             laxative or diuretic misuse&#xD;
&#xD;
          -  Use of any psychoactive or other medication known to affect mood or concentration in&#xD;
             the last 3 months&#xD;
&#xD;
          -  Have maintained 90% to 120% ideal body weight since menarche&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Wierenga, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Wierenga, PhD</last_name>
    <phone>858-534-8019</phone>
    <email>cwierenga@ucsd.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leanna Diaz, MS</last_name>
      <phone>858-534-1064</phone>
      <email>lmdiaz@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Megan Martinho, BS</last_name>
      <phone>858-534-1064</phone>
      <email>mamartinho@ucsd.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>November 13, 2020</last_update_submitted>
  <last_update_submitted_qc>November 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Christina Wierenga</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

